BioWorld

Oct. 12, 2004

DeCode Gets $24M To Study Genetics Of Infectious Disease

Working to better understand infectious diseases, the University of New Mexico is joining with DeCode Genetics Inc. and the National Center for Genome Resources in a five-year research agreement. (BioWorld Today) Read More

$3B Stem Cell Measure Likely To Pass, But Funds Problematic

From Embryonic To Adult: Recent Stem Cell Research

Rexahn's Hopper Includes More Than Phase I Cancer Compound

Clarification

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Jan 15, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 14, 2026.

3D rendering of antibody drug conjugated with cytotoxic payload

ADCs’ breakout 2025 and their still-unfinished potential

BioWorld

Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...

LINC01116 has prognostic value in lung cancer, study shows

BioWorld MedTech

Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...

SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

BioWorld Science

Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...